Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1995 Oct 1;153(7):935–938.

The dilemma of hereditary prostate cancer.

J C Nickel
PMCID: PMC1487375  PMID: 7553496

Abstract

The observation that a family history of prostate cancer significantly increases a man's risk of the disease (see pages 895 to 900 of this issue) highlights many of the ethical, emotional and pragmatic controversies in medical circles concerning the management of this common form of cancer. This editorial describes a patient's personal dilemma when he learns that his brother is dying of prostate cancer, a dilemma that illustrates the potential harms and benefits of early detection and treatment. Current evidence does not justify screening asymptomatic men for prostate cancer, but many Canadian physicians do practise early case detection for some patients with a high risk of the disease. Men with a family history of prostate cancer must be informed by their physicians about the known and unknown risks and benefits of early detection and treatment, before they undergo the cascade of diagnostic and therapeutic procedures associated with prostate cancer.

Full text

PDF
935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshaw M. A., Kaplan I. D., Cox R. C. Prostate cancer. Radiation therapy for localized disease. Cancer. 1993 Feb 1;71(3 Suppl):939–952. doi: 10.1002/1097-0142(19930201)71:3+<939::aid-cncr2820711409>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  2. Catalona W. J., Smith D. S., Ratliff T. L., Dodds K. M., Coplen D. E., Yuan J. J., Petros J. A., Andriole G. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991 Apr 25;324(17):1156–1161. doi: 10.1056/NEJM199104253241702. [DOI] [PubMed] [Google Scholar]
  3. Collins J. P. Detection of prostate cancer. CMAJ. 1995 Feb 1;152(3):328–329. [PMC free article] [PubMed] [Google Scholar]
  4. Denis L. J., Murphy G. P., Schröder F. H. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer. 1995 Mar 1;75(5):1187–1207. doi: 10.1002/1097-0142(19950301)75:5<1187::aid-cncr2820750521>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. Ford L. G., Brawley O. W., Perlman J. A., Nayfield S. G., Johnson K. A., Kramer B. S. The potential for hormonal prevention trials. Cancer. 1994 Nov 1;74(9 Suppl):2726–2733. doi: 10.1002/1097-0142(19941101)74:9+<2726::aid-cncr2820741823>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  6. Friedman G. D., Hiatt R. A., Quesenberry C. P., Jr, Selby J. V. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet. 1991 Jun 22;337(8756):1526–1529. doi: 10.1016/0140-6736(91)93207-p. [DOI] [PubMed] [Google Scholar]
  7. Johansson J. E., Adami H. O., Andersson S. O., Bergström R., Holmberg L., Krusemo U. B. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992 Apr 22;267(16):2191–2196. [PubMed] [Google Scholar]
  8. Krahn M. D., Mahoney J. E., Eckman M. H., Trachtenberg J., Pauker S. G., Detsky A. S. Screening for prostate cancer. A decision analytic view. JAMA. 1994 Sep 14;272(10):773–780. [PubMed] [Google Scholar]
  9. Oesterling J. E., Jacobsen S. J., Chute C. G., Guess H. A., Girman C. J., Panser L. A., Lieber M. M. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 1993 Aug 18;270(7):860–864. [PubMed] [Google Scholar]
  10. Optenberg S. A., Wojcik B. E., Thompson I. M. Morbidity and mortality following radical prostatectomy: a national analysis of Civilian Health and Medical Program of the Uniformed Services beneficiaries. J Urol. 1995 Jun;153(6):1870–1872. doi: 10.1016/s0022-5347(01)67334-8. [DOI] [PubMed] [Google Scholar]
  11. Quinlan D. M., Epstein J. I., Carter B. S., Walsh P. C. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991 May;145(5):998–1002. doi: 10.1016/s0022-5347(17)38512-9. [DOI] [PubMed] [Google Scholar]
  12. Walsh P. C., Partin A. W., Epstein J. I. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol. 1994 Nov;152(5 Pt 2):1831–1836. doi: 10.1016/s0022-5347(17)32396-0. [DOI] [PubMed] [Google Scholar]
  13. Zincke H., Oesterling J. E., Blute M. L., Bergstralh E. J., Myers R. P., Barrett D. M. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 1994 Nov;152(5 Pt 2):1850–1857. doi: 10.1016/s0022-5347(17)32399-6. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES